Why poor target validation is costing pharmaceutical businesses millions

It has been well documented that only 1 out of 10 compounds that enter clinical trials makes it to market¹. That is an astonishing 90% failure rate. It is hard to imagine hiring a lawyer or doctor or any professional who fails so often. Yet in our industry, it remains the norm.

0 min read
Written by
Andrew Taylor
  • Categories
  • Causaly
Receive the latest newsletter directly to your inbox

The cost of failure

Introducing Causaly

Research redefined


More on Causaly